Dup15q Alliance is the only national-based organization that is dedicated to supporting families and finding targeted treatments for individuals affected by dup15q syndrome. Together with our families, we believe in a better tomorrow.
Dup15q Syndrome is characterized by having an extra copy of a portion of chromosome 15 in the 11.2 – 13.1 region in combination with a number of symptoms that may include, hypotonia, epilepsy, cognitive delay, motor delays, autism, and similar facial features.
Families We Support
Number of Programs
Dollars to Research
Number of Clinics
Calling Dup15q Researchers, we are excited to be part of the CURE Epilepsy Partnership Grant. CURE Epilepsy funds research that has the potential to truly transform and save lives. CURE Epilepsy recently launched its new Rare Epilepsy Partnership Award! The...
Big things are coming and we don't want you to miss them! Sign up for our NEW Research and Clinical Trial Text Alerts! You can unsubscribe from text alerts at any time. Click the link below or Text "Alerts" to (847) 744-8904 to sign up!
On May 21st, our community came together as we went LIVE for our 5th Annual BIG GIVE Event: "Dup15q doesn't come with a manual, it comes with a family that never gives up." LIVE streams included members of our Dup15q Family including:Dup15q doctors, Researchers, other...
This site is intended to provide basic educational information about chromosome 15q11.2-13.1 duplication syndrome. It is not intended to, nor does it, constitute medical or other advice. Readers are warned not to take any action with regard to medical treatment or otherwise based on the information on this website or bulletin board without first consulting a physician. Dup15q Alliance does not promote or recommend any treatment, therapy, institution, or health care plan.
The information contained in this site is intended for your general education and information only and not for use in pursuing any treatment or course of action. Ultimately, the course of action in treating a given patient must be individualized after a thorough discussion with the patient’s physician(s).